In psoriatic arthritis, swelling and pitting oedema may be caused by diVerent pathogenic mechanisms: on one hand, the involvement of tenosynovial structures; on the other hand, the involvement of lymphatic vessels, which may be rarely implicated by the inXammatory process. This diVerent involvement is responsible for a diVerent response to therapy and a diVerent clinical outcome. In fact, patients with inXammation of the tenosynovial structures and normal lymphatic drainage have a more favourable clinical outcome and response to pharmacologic treatment, whilst patients aVected by psoriatic arthritis with chronic lymphatic vascular damage are characterized usually by resistance of oedema to therapy. In this study, we report two cases of psoriatic arthritis with distal extremity swelling and pitting oedema. In the Wrst patient, the swelling and pitting oedema were associated with lymphatic obstruction, as detected by lymphoscintigraphy. In the second, the predominant involvement of the tenosynovial structures, as shown by magnetic resonance, with normal lymphatic Xow, may have been the cause of arthritis with oedema. These diVerent pathogenetic mechanisms were associated with diVerent response to therapy. Nevertheless, oedema was resistant to therapy in both patients probably because of other unknown factors, which inXuence therapy and clinical outcome.
Introduction
Lymphoedema is well known in rheumatoid arthritis (RA) [1] , but its association with psoriatic arthritis (PsA) is rare. Until now, few cases have been described in literature [2] [3] [4] [5] [6] [7] [8] . Lymphoedema occasionally occurs in the upper limbs and the legs in RA. The swelling and oedema predominantly involve the upper limbs with asymmetric pattern in PsA. The lymphatic vessels or the tenosynovial structures may be involved in the inXammatory process. Their involvement may be revealed by lymphoscintigraphy and magnetic resonance imaging (MRI) and is responsible for a diVerent response to therapy and a diVerent clinical outcome. In consideration of these evidences, two diVerent pathogenetic mechanisms have been hypothesized which may be associated with distal extremity swelling and pitting oedema in PsA [9] .
In this study, we report two cases of PsA with distal extremity swelling and pitting oedema caused by involvement of diVerent anatomical structures.
Case reports
Case 1 RM was a 38-year-old man aVected by psoriasis. At the age of 21, he developed an erosive polyarthropathy involving the shoulder, elbow, wrist, carpal, distal interphalangeal (DIP), proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints, knee and metatarsophalangeal (MTP) joints bilaterally. He also had a swelling and pitting oedema in the right hand and forearm. A diagnosis of PsA was made and he was treated with gold salts, methotrexate at a weekly dose of maximum 10 mg, methylprednisolone (16-4 mg/day) and anti-inXammatory non-steroid drugs (NSAIDs) without clinical improvement. At the age of 38 years, he was admitted to our clinic because of active asymmetrical arthritis and lymphoedema of the right hand and forearm. The physical examination revealed a marked swelling and pitting oedema of the right hand extending to below the elbow, tenderness of MCF, PIP and DIP joints of both hands, and swelling and tenderness of both elbows and left knee. Laboratory investigations revealed erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), blood count, liver and renal function parameters within normal range. Rheumatoid factor and antinuclear antibodies were negative. X-rays of both hands showed multiple erosions of wrist, carpal, PIP and DIP joints. Quantitative lymphoscintigraphy 99m Tc-labelled nanocoll was performed on both arms. Colloid movement from the injection site on the dorsum of the right hand to the ipsilateral axillary nodes was absent, whilst left lymphatic drainage was normal ( Fig. 1 ). MRI revealed a subcutaneous oedema without involvement of the synovial tendon sheaths. The patient underwent a manual lymphatic drainage and a treatment with etanercept (25 mg twice weekly), methotrexate (10 mg weekly), methylprednisolone (4 mg daily) and NSAID(s) therapy with a rapid clinical improvement of arthritis after 2-3 months of therapy, but without improvement of oedema after 12 months of treatment.
Case 2
A 55-year-old woman was suVering from PsA since the age of 52 years. After the date of the diagnosis, her arthritis was treated with methotrexate (7.5 mg weekly) and NSAID(s) with good clinical improvement. At the age of 54 years, she was admitted to our clinic due to the development of swelling and pitting oedema of the left hand and forearm. On clinical examination, she showed a marked swelling and oedema of the left forearm and hand, and tenderness of MCP, PIP and DIP of the right hand. Psoriasis in both hands and onychodystrophy were observed. Biohumoral laboratory tests showed ESR 28 mm/h, CRP 0.094 mg/dl and normal blood count and protein electrophoresis. Rheumatoid factor and antinuclear antibodies were negative. X-rays of hands showed a subchondral microcyst at the head of the third right MCP joint. Quantitative lymphoscintigraphy 99m Tc-labelled nanocoll revealed normal lymphatic drainage in both arms. MRI of the left hand showed soft tissue oedema over the dorsum and extensor tenosynovitis (Fig. 2) . The patient was started on etanercept (25 mg twice weekly), methotrexate (10 mg weekly), methylprednisolone (8 mg daily) and NSAID(s) therapy. After 1 year of therapy, the swelling and the pitting oedema of the left hand continued to be present.
Discussion
Lymphoedema is an unusual extra-articular feature of RA and rarely has been described in PsA. According to our knowledge, only few patients with PsA and distal extremity swelling with pitting oedema have been reported in literature [2, [4] [5] [6] . In all cases, oedema predominantly aVected the upper limbs with asymmetrical pattern and its onset was not directly connected with the severity of arthritis. Response to therapy and clinical outcome were diVerent in relation to involved anatomical structures (lymphatic vessels or tenosynovial structures). Indeed, in some patients oedema and swelling were chronic and resistant to pharmacological therapy, whilst other patients responded to therapy with complete remission.
Similar clinical pictures were also reported in patients with RA [1, 10] , even though in these patients oedema and swelling aVected the upper limbs and, occasionally, the legs.
Many other clinical conditions may be associated with oedema and swelling described in patients with PsA and RA. In 1985, McCarty et al. [11] observed ten patients aVected by remitting seronegative symmetrical synovitis with pitting oedema of the upper and/or lower limbs (RS3PE syndrome), which was considered to be secondary to vigorous tenosynovitis and synovitis of the underlying joints [9] . The clinical Wndings of RS3PE syndrome have also been observed in other rheumatic diseases such as polymyalgia rheumatica, giant cell arteritis, ankylosing spondylitis, late-onset undiVerentiated spondyloarthropathies and acute sarcoidosis [9, [12] [13] [14] .
Other forms of lymphoedema may be secondary to lymphatic damage or compression by mastectomy [15] , tumours and infections (e.g. Wlariasis) [3, 9] All these clinical pictures must be distinguished from lymphoedema associated with PsA.
In 1999, Salvarani et al. [9] described two cases of distal swelling with pitting oedema in PsA characterized by two diVerent lesions based on involved anatomic structures with diVerent response to therapy and clinical outcome. In these two PsA patients, oedema and swelling were a direct consequence of involvement of the lymphatic vessels by the inXammatory process, as demonstrated by lymphoscintigraphy, which revealed an altered lymphatic drainage with an obstructed Xow in the aVected limb. It has been hypothesized that in these cases, the inXammatory products from the synovium are deposited in the adjacent lymphatic vessels, leading to lymphangitis and lymphatic obstruction [8] . The chronic lymphatic vascular damage can induce abnormalities of the lymphatic vessels (dilatation, lack of fenestration or dermal distal blind loops) with progressive and deWnitive damage and Xow obstruction [3, 16, 17] . These anatomical damages could explain the usual resistance of oedema to therapy in patients with PsA.
On the contrary, cases reporting distal swelling with pitting oedema in PsA, characterized by inXammation of tenosynovial structures, conWrmed by MRI, and normal lymphatic drainage, were characterized by a more favourable clinical outcome. In fact, these patients responded to psoriatic treatment with remission of the inXammatory process responsible for tenosynovitis and complete resolution of anatomical damage in the tenosynovial structures.
Our two cases support the evidence of two diVerent lesions and pathogenetic mechanisms associated with distal swelling and pitting oedema in PsA. Whilst estimation of the involved anatomic structures by clinical examination was diYcult, the type of lesion and the diVerent pathogenetic mechanisms were clearly deWned using MRI and lymphoscintigraphy.
In the Wrst patient, the swelling and pitting oedema were associated with lymphatic obstruction, as shown by lymphoscintigraphy, and absence of tenosynovitis on MRI. In the second, the predominant involvement of the tenosynovial structures on MRI, with normal lymphatic Xow on lymphoscintigraphy, may have been the cause of the arthritis with oedema. These diVerent pathogenetic mechanisms were associated with diVerent response to therapy.
In the Wrst patient, oedema and swelling associated with lymphatic Xow obstruction were resistant to therapy, according to the case reports of other authors. Nevertheless, in the second patient with prominent involvement of the tenosynovial structures, oedema did not respond to the antiinXammatory and immunosuppressive therapy and to etanercept, a soluble TNF receptor fusion protein, which mediates its anti-inXammatory eVects by binding to TNF and preventing it from interacting with cell-surface receptors. On the contrary, in this patient, oedema and arthritis continued to be present.
Considering this abnormal response to therapy, we hypothesized that in PsA patients, pathogenesis of distal extremity swelling with pitting oedema is characterized by other unknown factors, which inXuence the therapy and clinical outcome. Nevertheless, further studies are necessary to conWrm this hypothesis.
